Regencell Bioscience Holdings Limited ( RGC) - Stock Earnings
RGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -3.2 million USD | — USD |
| 2023Q1 | -1321 USD | — USD |
| 2023Q3 | -2.6 million USD | — USD |
RGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -1.3 million USD | 0 USD |
| 2022 | -7.4 million USD | 0 USD |
| 2023 | -5.9 million USD | — USD |
RGC
Price: $23.75
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -2421
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Hong Kong
Volume: 700
Ebitda: 521.8 millionMarket Capitalization: 14.9 billion